Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation

This study has been completed.
Sponsor:
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01014455
First received: November 13, 2009
Last updated: July 25, 2011
Last verified: July 2011

November 13, 2009
July 25, 2011
January 2010
March 2011   (final data collection date for primary outcome measure)
  • Preoperative Carbon Monoxide Levels [ Time Frame: the morning of surgery ] [ Designated as safety issue: No ]
  • Exhaled CO Level Measured Immediately Prior to Surgery [ Time Frame: The median time from study assessment at POE to surgery was 1 day with an interquartile range of 1 to 3 days. ] [ Designated as safety issue: No ]
    On the morning of surgery, as matter of clinical routine all patients receiving surgery requiring anesthesia services at one of the two main surgical facilities at Mayo Clinic Rochester and who self-report as a current smoker are asked about their typical cigarette consumption (cigarettes per day), if they have smoked cigarettes today, and have their exhaled CO levels measured (Micro Smokerlyzer; Bedfont, United Kingdom). This information is entered into the clinical record. The CO monitors are maintained by the Division of Respiratory Therapy, including regular calibration.
Same as current
Complete list of historical versions of study NCT01014455 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation
Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation

Smoking causes 90% of all lung cancer deaths among men and 80% of lung cancer deaths in women. Surgery is a great opportunity to help patients quit smoking. Smokers are at increased risk for heart, lung, and wound complications around the time of surgery. Even a brief abstinence from smoking can produce benefits. Surgery can also motivate smokers to quit spontaneously. If the investigators can take advantage of this great opportunity, they may be able to help many smokers quit using simple means. However, currently most smokers continue to smoke cigarette on the morning before surgery, as shown by the measurement of exhaled carbon monoxide (CO) on the morning of surgery. CO is one of the many poisons in cigarette smoke. It only stays in the body for a few hours. By asking smokers to blow into a small machine, the investigators can test the CO level in the smokers' body and thus know if they have just smoked within the past few hours. The goal of this study is to determine the role of carbon monoxide monitoring as a means to decrease cigarette smoking before surgery. The investigators will identify a group of smokers who are scheduled for surgery and invite them to participate. One or two days before surgery, half of the patients will receive a brief advice about quit smoking. The other half of patients will be told that their CO will be checked before surgery, in addition to the brief advice. On the morning of surgery, the investigators will then check their CO level to determine if they have followed the advice. In order to have a better understanding about the factors influencing patients' intent to quit smoking, the investigators will ask all study participants to fill out a questionnaire. The questionnaire is constructed according to behavioral theories which provide good framework for studying people's intent and behavior. If the investigators are successful, they will determine how much of an impact the message of CO testing has on smoking before surgery. The investigators will also gain insights into facilitators and barriers to smoking cessation around the time of surgery. The brief intervention evaluated in this study has potential to be disseminated and to promote the long term health of surgical patients.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Smoking
  • Behavioral: Informing surgical patients about CO monitoring
    A brief intervention that recommends preoperative fasting from cigarettes and that informs patients that their smoking status will be checked before surgery using inhaled CO monitoring will decrease their exposure to cigarette smoke prior to surgery
  • Behavioral: a brief intervention recommending preoperative abstinence from smoking
    a brief intervention that recommends fasting but does not mention that CO will be checked
  • Experimental: CO reminder
    A brief intervention that recommends preoperative fasting from cigarettes and that informs patients that their smoking status will be checked before surgery using inhaled CO monitoring will decrease their exposure to cigarette smoke prior to surgery
    Intervention: Behavioral: Informing surgical patients about CO monitoring
  • Placebo Comparator: no CO reminder
    a brief intervention that recommends fasting but does not mention that CO will be checked
    Intervention: Behavioral: a brief intervention recommending preoperative abstinence from smoking

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
169
June 2011
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Patients ≥ 18 yrs. scheduled for elective non-cardiac surgery at Mayo Clinic Rochester;
  2. Current smoking, defined as > 100 cigarettes lifetime consumption and self-report of smoking every day.

Exclusion Criteria:

  1. An inability to understand consent procedures;
  2. Inability to complete a written questionnaire.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01014455
09-006998
Yes
David O. Warner, Mayo Clinic
Mayo Clinic
Not Provided
Principal Investigator: David O Warner, MD Mayo Clinic
Mayo Clinic
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP